[Federal Register Volume 82, Number 57 (Monday, March 27, 2017)]
[Notices]
[Page 15184]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-06003]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Institute of Standards and Technology


Prospective Grant of Exclusive Patent License

AGENCY: National Institute of Standards and Technology, Department of 
Commerce.

ACTION: Notice; prospective grant of exclusive patent license.

-----------------------------------------------------------------------

SUMMARY: The National Institute of Standards and Technology (``NIST''), 
U.S. Department of Commerce, is contemplating the grant of an exclusive 
license in the United States of America, its territories, possessions 
and commonwealths, to NIST's interest in the invention embodied in U.S. 
Patent Application No. 62/302,855, titled ``Prostate Cancer Detection 
Using Western Blot Analysis,'' (NIST Docket No. 16-007) to McJimpsey 
Biotechnologies, Inc. The grant of the license would be for prostate 
cancer detection.

FOR FURTHER INFORMATION CONTACT: Donald Archer, National Institute of 
Standards and Technology, Technology Partnerships Office, 100 Bureau 
Drive, Stop 2200, Gaithersburg, MD 20899, (301) 975-2522; 
[email protected].

SUPPLEMENTARY INFORMATION: The prospective exclusive license will be 
royalty bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be 
granted unless, within fifteen (15) days from the date of this 
published Notice, NIST receives written evidence and argument which 
establish that the grant of the license would not be consistent with 
the requirements of 35 U.S.C. 209 and 37 CFR 404.7. The Provisional 
Patent Application was filed on March 3, 2016 and describes systems and 
methods for detecting prostate cancer.

Phillip Singerman,
Associate Director for Innovations and Industry Services.
[FR Doc. 2017-06003 Filed 3-24-17; 8:45 am]
 BILLING CODE 3510-13-P